BillionToOne Launches Northstar Origin Liquid Biopsy Test
Menlo Park, California, USA, September 1, 2026 BillionToOne has launched Northstar Origin™, a new liquid biopsy add-on test designed...
Cardiovascular Care
Advertisement
CytoSorbents Advances DrugSorb-ATR FDA Regulatory Path
Princeton, New Jersey, USA, September 2, 2026 CytoSorbents Corporation has announced new real-world clinical data showing that use of...
Australia Expands Access to MDMA and Psilocybin Therapies Under New TGA Framework
VANCOUVER, British Columbia, May 29, 2026 Optimi Health Corp. has welcomed new recommendations issued by Australia’s Therapeutic Goods Administration...
Leica Biosystems and CellCarta Advance AI-Driven Companion Diagnostics Worldwide
MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...
Cardiosense Wins FDA De Novo for AI Heart Failure Technology
CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
Advertisements
TCAI and St. David’s Medical Center Advance Cardiac Rhythm Innovation
Austin, Texas, USA — May 22, 2026 The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center has...
Advertisement
